Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 8, 2002, Pages 2561-2565

  Van den Aardweg, Gerard J M J ^a   Naus, Nicole C ^a   Verhoeven, Anette C A ^a   De Klein, Annelies ^a   Luyten, Gregorius P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; UVEA MELANOMA; X IRRADIATION;

CELL SURVIVAL; DNA DAMAGE; DNA, NEOPLASM; HUMANS; MELANOMA; NEOPLASM METASTASIS; RADIATION DOSAGE; RADIATION TOLERANCE; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0036319653     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Epidemiologic aspects of uveal melanoma
2. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: Twenty years' experience
3. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: Evaluation of 175 patients treated with 150 Gy from 1981-1989
4. Results of ruthenium irradiation of uveal melanomas: The Dutch experience
5. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma: A meta-analysis of studies including 1,066 patients
6. Radiation therapy for choroidal melanoma
7. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival
8. Treatment of juxtapapillary melanomas
9. Long-term results of 1251 irradiation of uveal melanoma
10. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma: A prospective, randomized, dynamically balanced trial
11. 125I Plaque therapy for uveal melanoma: Analysis of the impact of time and dose factors on local control
12. Results of proton radiotherapy for uveal melanomas
13. Ten-year follow-up of helium ion therapy for uveal melanoma
14. Gamma knife stereotactic radiosurgery for uveal melanoma: Clinical results after 2 years
15. Gamma knife radiosurgery in the treatment of ocular melanoma
16. Local tumour control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma
17. Radiation biology of malignant melanoma
18. Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line
19. Effects of gamma radiation on the OM431 human ocular melanoma cell line
20. The radiosensitivity of uveal melanoma cells and the cell survival curve
21. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes
22. Expression of MAGE genes in ocular melanoma cell lines
23. Establishment and characterization of an uveal-melanoma cell line
24. Establishment and characterization of primary and metastatic uveal melanoma cell lines
25. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation
26. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy
27. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
28. Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data
29. Radiosensitivity of new and established human melanoma cell lines: Comparison of [3H]thymidine incorporation and soft agar clonogenic assays
30. Clinical radiobiology of malignant melanoma
31. Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation
32. Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
33. Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene
34. Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines
35. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors